Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

(MedPage Today) -- The FDA approved ropeginterferon alfa-2b (Besremi) injection to treat adults with essential thrombocythemia, the first new therapy for the chronic blood cancer since the 1997 approval of anagrelide. A national survey showed...